Landscapes / Companies
Xuanzhu Biopharmaceutical Co., Ltd. not checked
FollowEvery new trial, moved date and filing, and a Monday email
Drugs
7
in active trials · 10 in all
Trials
11 active
24 since 2021
Drugs7
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
Anaprazolenot checked |
Antiulcer, benzimidazole derivative |
On the market | 19 Feb 2027Phase 3 trial completes | ||
| How it works | Lowers stomach acid | ||||
| Next date | 19 Feb 2027 · Phase 3 trial completes | ||||
| Also tested for | Reflux Esophagitis (RE), Drug-drug Interaction Study and 4 more | ||||
| Open drug page | |||||
— |
Phase 3 | — | |||
| Also tested for | Advanced Breast Cancer | ||||
| Open drug page | |||||
— |
Phase 1/2 | — | |||
| Also tested for | Locally Advanced or Metastatic Solid Tumors, Locally Advanced or Metastatic Non-small Cell Lung Cancer | ||||
| Open drug page | |||||
— |
Phase 1 | Dec 2026Phase 1 trial completes | |||
| Next date | Dec 2026 · Phase 1 trial completes | ||||
| Also tested for | Advanced Solid Tumors | ||||
| Open drug page | |||||
— |
Phase 1 | — | |||
| Also tested for | Advanced Solid Tumor | ||||
| Open drug page | |||||
— |
Phase 1 | — | |||
| Also tested for | Advanced Solid Tumor | ||||
| Open drug page | |||||
— |
SignalChem Lifesciences Corporation |
Phase 1 | — | ||
| Also tested for | Advanced Solid Tumor, NSCLC | ||||
| Open drug page | |||||
About
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 Industry-sponsored drug trials since 2021